Nanodrug Delivery Strategies to Signaling Pathways in Alopecia
X Wu, Y Du - Molecular Pharmaceutics, 2023 - ACS Publications
Over 50% of the global population suffers from hair loss. The mixed results in the treatment
of hair loss reveal the limitations of conventional commercial topical drugs. One the one …
of hair loss reveal the limitations of conventional commercial topical drugs. One the one …
Molybdenum Nanoparticles Ameliorate Psoriatic Lesions by Inhibiting the ROS/NF-κb Signaling Axis
J Guo, Q Xiao, Y Lu, J Gao, P Ning, C Jia… - ACS Applied Nano …, 2024 - ACS Publications
Psoriasis is a chronic inflammatory disease that affects more than 60 million people
worldwide. Its pathogenesis involves the interplay of immune and oxidative stress …
worldwide. Its pathogenesis involves the interplay of immune and oxidative stress …